ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narayanan, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narayanan, S
Annals of Clinical and Laboratory Science, Vol 29, Issue 4, 275-280
Copyright © 1999 by Association of Clinical Scientists

Articles

Multifunctional roles of thrombin

S Narayanan

Thrombin is an unique molecule that functions both as a procoagulant and anticoagulant. In its procoagulant role it activates platelets through its receptor on the platelets. It regulates its own generation by activating coagulation factors V, VIII and even XI resulting in a burst of thrombin formation. It activates factor XI, thus preventing fibrin clots from undergoing fibrinolysis. Thrombin not only cleaves fibrinogen to fibrin, but also through the activation of factor XIII effects the cross-linking of fibrin monomers to produce a firm fibrin clot. Thrombin's role as an anticoagulant is mediated through binding to thrombomodulin, a receptor protein on the endothelial membrane of the blood vessel, initiating a series of reactions that leads to fibrinolysis. Thrombin has chemotactic properties enabling it to exert its effects during inflammation and vascular injury. It has a mitogenic effect stimulating growth of mammalian cells, fibroblasts and macrophage-like tumor cell lines. It has also been implicated in brain development. A molecule with multifunctional roles such as thrombin has its activity in vivo modulated by only a few endogenous inhibitors.


This article has been cited by other articles:


Home page
 BloodHome page
J. T. B. Crawley, J. K. Lam, J. B. Rance, L. R. Mollica, J. S. O'Donnell, and D. A. Lane
Proteolytic inactivation of ADAMTS13 by thrombin and plasmin
Blood, February 1, 2005; 105(3): 1085 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K.-i. Aihara, H. Azuma, N. Takamori, Y. Kanagawa, M. Akaike, M. Fujimura, T. Yoshida, S. Hashizume, M. Kato, H. Yamaguchi, et al.
Heparin Cofactor II Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals
Circulation, June 8, 2004; 109(22): 2761 - 2765.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. S. Wolberg, D. M. Monroe, H. R. Roberts, and M. Hoffman
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk
Blood, April 15, 2003; 101(8): 3008 - 3013.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. IDELL, A. P. MAZAR, P. BITTERMAN, S. MOHLA, and A. L. HARABIN
Fibrin Turnover in Lung Inflammation and Neoplasia
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 578 - 584.
[Full Text]

Home page
 J. Immunol.Home page
X. Liu and T. H. Piela-Smith
Fibrin(ogen)-Induced Expression of ICAM-1 and Chemokines in Human Synovial Fibroblasts
J. Immunol., November 1, 2000; 165(9): 5255 - 5261.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. A. Weinstein, H. Li, J. A. Lawson, J. Rokach, G. A. FitzGerald, and P. H. Axelsen
Prothrombinase Acceleration by Oxidatively Damaged Phospholipids
J. Biol. Chem., July 21, 2000; 275(30): 22925 - 22930.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association of Clinical Scientists.